Virtuoso Therapeutics
Focus: Virtuoso Therapeutics is a public-stage biotechnology company headquartered in San Mateo, CA, focused on developing therapeutic antibodies for oncology. The company is in early clinical development with a Phase 1 program and a medical device study in bladder lesion management.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
1+29 this month
Hot — 34 jobs added in 30d
Net +29 (34 new, 5 removed). Aggressive expansion phase.
Should You Work at Virtuoso Therapeutics?
AI assessmentEarly-stage oncology antibody player with public-market stability but limited hiring and very early clinical validation—suitable only for researchers comfortable with long development timelines.
Why Work Here
- Public company status provides liquidity and stability compared to pre-revenue biotech ventures.
- Focused therapeutic antibody platform targeting oncology offers concentrated technical depth for specialized researchers.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
The study is to evaluate the use of the Virtuoso Endoscopy System to perform safe and effective bladder lesion excisions.
Bladder NeoplasmVP301
Solid Tumors, AdultClinical Trials (1)
Help build intelligence for Virtuoso Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.